Product
product GREENYNBIO
Insumate®
Bitter melon extract (Insumate®)
Insumate® bitter melon extract contains the patented amino peptide sequence mcIRBP-19, which is a scientific-recognized active compound for glucose modulation. The clinical efficacy of Insumate® has been validated by two officially clinical studies. It is easy to be absorbed by human body due to the low molecular weight of mcIRBP-19. The underlying mechanism of glucose modulation has been verified by in-vitro and animal models.
Insumate® (NDIN No. 1256) is the first USFDA-approved bitter melon product.
Insumate® is produced by a unique fabrication process at low temperatures to ensure the product quality and remain the activity of mcIRBP-19. Currently, Greenyn is the only provider and ODM for Insumate®-associated products.
Insumate® (NDIN No. 1256) is the first USFDA-approved bitter melon product.
Insumate® is produced by a unique fabrication process at low temperatures to ensure the product quality and remain the activity of mcIRBP-19. Currently, Greenyn is the only provider and ODM for Insumate®-associated products.
Product Description
Characteristics of Insumate®
- Organic solvents-free extraction process, high safety (genotoxicity, acute toxicity, subchronic toxicity, and teratogenic toxicity)
- High level of active compound
- Multiple international patents and three major international innovation awards
- 6 journal articles and 2 clinical studies
- The world’s first USFDA-approved bitter melon product.
- Clear underlying mechanism of glucose modulation
Comparsion of Bitter Melon Peptide Products:
Publication
Patent
Innovation Award
Silver Medal by Germany’s IENA Nuremburg
Special Award by the Iranian Inventor’s Association
Silver Medal by INPEX of Pittsburgh, U.S.
Gold Medal by Switzerland’s Geneve Salon International Des Invention
Taiwan Biotechnology Award
Patent Technology Gold Award by Republic of China Fine Manufacturer Association
Top Brand of Ethnic Chinese in Biotechnology and Foods
National Innovation Award
Gold Medal by World Invention Innovation Contest
Gold Medal by AII American DAVINCI International
Innovation and Invention
News Report
Yahoo News: Insumate®- Patented Peptide Sequence mcIRBP-19: A Boon for Diabetics Says Greenyn Biotechnology
NutraIngredients-Asia: ’Plant insulin’ from bitter melon backed for fight against diabetes
